Fluvoxamine, a common and affordable antidepressant, significantly reduces bmedlinkpersistent fatigue/medlink and debilitating lethargic symptoms/b

FRIDAY, April 3, 2026 -- For patients with postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), fluvoxamine seems...

WEDNESDAY, April 1, 2026 — A common antidepressant appears to help reduce fatigue in people living with long COVID, a new study...

WEDNESDAY, April 1, 2026 — A common antidepressant appears to help reduce fatigue in people living with long COVID, a new study says.Fluvoxamine...

A new study from researchers at The University of Texas MD Anderson Cancer Center demonstrates that a specialized high-dose type of radiation...

Low back pain is one of the most common health problems in the world. It affects people of all ages, but it becomes more common as people get older....

- Earliest timepoint in an open-label extension with this magnitude of risk reduction at 44.7% in ACM (p0.0001) and 49.3% in CVM (p0.0001) ......

Women with long COVID had more than double the risk of developing cardiovascular disease compared with women without long COVID. TetianaKtv/...

Choosing whether to use chemotherapy after breast cancer surgery is one of the hardest decisions patients and doctors face. Chemotherapy can save...